Live feed08:54:53·450dINSIDERFilingvia QuantisnowDirector Ballantyne John was granted 4,126 shares, acquired $4,093,116 worth of shares (132,036 units at $31.00) and converted options into 2,560,553 shares (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.GCTK· GlucoTrack Inc.Health CareOriginal source